Realizing the promise of precision medicine in psychiatry is a laudable and beneficial
endeavor, since it should markedly reduce morbidity and mortality and, in effect, alleviate the …

Neuropsychiatric disorders and dementia represent a major cause of disability and high cost
in developed societies. Most disorders of the central nervous system (CNS) share some …

A growing body of evidence now suggests that precision psychiatry, an interdisciplinary field
of psychiatry, precision medicine, and pharmacogenomics, serves as an indispensable …

Psychiatric genomics is providing insights into the nature of psychiatric conditions that in
time should identify new drug targets and improve patient care. Less attention has been paid …

Personalized medicine (personalized psychiatry in a specific setting) is a new model
towards individualized care, in which knowledge from genomics and other omic pillars …

Most psychiatric disorders including major depressive disorder (MDD), anxiety disorders,
bipolar disorder, obsessive-compulsive disorder(OCD), schizophrenia, autism, and attention …

Psychotropic medications are used for numerous psychiatric and neurologic disorders, and
are associated with in some cases life-threatening adverse effects, high acquisition costs …

Personalized medication that is based on pharmacogenetic data has long been expected to
improve the efficacy of treatments for neurological and psychiatric disorders, including …

Psychiatry is increasingly combining new pharmacogenomic findings with therapeutic drug
monitoring (TDM) to improve the safety and efficacy of pharmacotherapy. However, a …

The holistic approach of personalized medicine, merging clinical and molecular
characteristics to tailor the diagnostic and therapeutic path to each individual, is steadily …